These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38637946)

  • 1. Parameter grouping and co-estimation in physiologically based kinetic models using genetic algorithms.
    Tsiros P; Minadakis V; Li D; Sarimveis H
    Toxicol Sci; 2024 Jun; 200(1):31-46. PubMed ID: 38637946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Permeability-Limited Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctanoic acid (PFOA) in Male Rats.
    Cheng W; Ng CA
    Environ Sci Technol; 2017 Sep; 51(17):9930-9939. PubMed ID: 28759222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.
    Worley RR; Yang X; Fisher J
    Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the uncertainty in the validation of PBPK models: A case-study for PFOS and PFOA.
    Fàbrega F; Nadal M; Schuhmacher M; Domingo JL; Kumar V
    Regul Toxicol Pharmacol; 2016 Jun; 77():230-9. PubMed ID: 26993749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK).
    Verner MA; Loccisano AE; Morken NH; Yoon M; Wu H; McDougall R; Maisonet M; Marcus M; Kishi R; Miyashita C; Chen MH; Hsieh WS; Andersen ME; Clewell HJ; Longnecker MP
    Environ Health Perspect; 2015 Dec; 123(12):1317-24. PubMed ID: 26008903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBPK modeling for PFOS and PFOA: validation with human experimental data.
    Fàbrega F; Kumar V; Schuhmacher M; Domingo JL; Nadal M
    Toxicol Lett; 2014 Oct; 230(2):244-51. PubMed ID: 24440341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis.
    Wambaugh JF; Barton HA; Setzer RW
    J Pharmacokinet Pharmacodyn; 2008 Dec; 35(6):683-712. PubMed ID: 19130186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating parameter availability for physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoic acid (PFOA) in zebrafish.
    Khazaee M; Ng CA
    Environ Sci Process Impacts; 2018 Jan; 20(1):105-119. PubMed ID: 29265128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian Refinement of the Permeability-Limited Physiologically Based Pharmacokinetic Model for Perfluorooctanoic Acid in Male Rats.
    Cheng W; Ng CA
    Chem Res Toxicol; 2021 Nov; 34(11):2298-2308. PubMed ID: 34705448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages.
    Loccisano AE; Longnecker MP; Campbell JL; Andersen ME; Clewell HJ
    J Toxicol Environ Health A; 2013; 76(1):25-57. PubMed ID: 23151209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex, age, and species differences of perfluorooctanoic acid modeled by flow- versus permeability-limited physiologically-based pharmacokinetic models.
    Choi GW; Kang DW; Kim JH; Cho SJ; Lee YB; Kwon IH; Cho HY
    Toxicology; 2024 Jun; 505():153806. PubMed ID: 38642821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using physiologically based pharmacokinetic (PBPK) modeling for dietary risk assessment of titanium dioxide (TiO2) nanoparticles.
    Bachler G; von Goetz N; Hungerbuhler K
    Nanotoxicology; 2015 May; 9(3):373-80. PubMed ID: 25058655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically-Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles.
    Minnema J; Vandebriel RJ; Boer K; Klerx W; De Jong WH; Delmaar CJE
    Small; 2023 May; 19(21):e2207326. PubMed ID: 36828794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A generic avian physiologically-based kinetic (PBK) model and its application in three bird species.
    Baier V; Paini A; Schaller S; Scanes CG; Bone AJ; Ebeling M; Preuss TG; Witt J; Heckmann D
    Environ Int; 2022 Nov; 169():107547. PubMed ID: 36179644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of placental and lactational pharmacokinetics of PFOA and PFOS in the pregnant, lactating, fetal and neonatal rat using a physiologically based pharmacokinetic model.
    Loccisano AE; Campbell JL; Butenhoff JL; Andersen ME; Clewell HJ
    Reprod Toxicol; 2012 Jul; 33(4):468-490. PubMed ID: 21872655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-titanium dioxide exacerbates the harmful effects of perfluorooctanoic acid on the health of mussels.
    Sun B; Hu M; Lan X; Waiho K; Lv X; Xu C; Wang Y
    Environ Int; 2024 May; 187():108681. PubMed ID: 38663234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
    Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
    Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying mixture effects on uptake and tissue distribution of PFAS in zebrafish (Danio rerio) using physiologically based kinetic (PBK) modelling.
    Golosovskaia E; Örn S; Ahrens L; Chelcea I; Andersson PL
    Sci Total Environ; 2024 Feb; 912():168738. PubMed ID: 38030006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model.
    Loccisano AE; Campbell JL; Butenhoff JL; Andersen ME; Clewell HJ
    Reprod Toxicol; 2012 Jul; 33(4):452-467. PubMed ID: 21565266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.
    Kudo N; Kawashima Y
    J Toxicol Sci; 2003 May; 28(2):49-57. PubMed ID: 12820537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.